Danske Bank A/S Roivant Sciences Ltd. Transaction History

Danske Bank A/S

  • $1.95 Trillion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 19, 2025
BUY
$10.74 - $15.28 $97,734 - $139,048
9,100 New
9,100 $137,000
Q2 2025

Dec 18, 2025
BUY
$9.08 - $11.62 $76,272 - $97,608
8,400 Added 1200.0%
9,100 $102,000
Q1 2025

Dec 18, 2025
SELL
$10.09 - $12.08 $84,756 - $101,472
-8,400 Reduced 92.31%
700 $7,000

Others Institutions Holding ROIV

# of Institutions
385
Shares Held
444M
Call Options Held
6.03M
Put Options Held
2.52M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $14.3B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Danske Bank A/S Portfolio

Follow Danske Bank A/S and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

News

Stay updated on Danske Bank A/S with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email